Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · July 18, 2023

Development and Validation of a Prediction Score for HCC Recurrence Risk After Liver Transplantation

Liver Transplantation


Additional Info

Disclosure statements are available on the authors' profiles:

Liver Transplantation
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Liver Transpl. 2023 Jul 01;29(7)683-697, BV Tran, D Moris, D Markovic, H Zaribafzadeh, R Henao, Q Lai, SS Florman, P Tabrizian, B Haydel, RM Ruiz, GB Klintmalm, DD Lee, CB Taner, M Hoteit, MH Levine, U Cillo, A Vitale, EC Verna, KJ Halazun, AD Tevar, A Humar, WC Chapman, N Vachharajani, F Aucejo, J Lerut, O Ciccarelli, MH Nguyen, ML Melcher, A Viveiros, B Schaefer, M Hoppe-Lotichius, J Mittler, TL Nydam, JF Markmann, M Rossi, C Mobley, M Ghobrial, AN Langnas, CA Carney, J Berumen, GT Schnickel, DL Sudan, JC Hong, A Rana, CM Jones, TM Fishbein, RW Busuttil, AS Barbas, VG Agopian

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading